Coronary thrombosis: pathogenesis and prevention

G V Born1

  • 1Pathopharmacology Unit, William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, UK.

Insights

Plaque fissuring, a key event in acute myocardial infarction, predominantly occurs in lipid-rich plaques at sites of high stress. This finding helps explain why some antiplatelet drugs are less effective for plaque-related thrombosis.

Area of Science:

  • Cardiovascular Biology
  • Biomedical Engineering
  • Pathology

Background:

  • Acute myocardial infarction (AMI) is primarily triggered by atheromatous plaque rupture.
  • The mechanisms and locations of plaque fissuring remain incompletely understood.
  • Understanding plaque vulnerability is crucial for preventing thrombotic events.

Purpose of the Study:

  • To identify plaque characteristics associated with fissuring.
  • To determine the distribution and common sites of plaque fissures.
  • To investigate the role of arterial spasm in plaque fissuring.

Main Methods:

  • Relating mechanical properties of plaques to their cellular and biochemical characteristics.
  • Quantifying the distribution of plaque fissures.
  • Utilizing computer modeling to predict stress concentration sites.
  • Assessing the presence of medial smooth muscle at fissure sites.

Main Results:

  • Fissures predominantly occur in plaques with localized lipid pools.
  • The most frequent site of fissuring corresponds to areas of maximal stress concentration predicted by computer models.
  • Arterial spasm is not consistently involved, as fissures often occur where medial smooth muscle is absent.

Conclusions:

  • Plaque fissuring is linked to specific mechanical and compositional properties, particularly lipid pools and stress concentrations.
  • The findings suggest that treatments targeting platelet aggregation may have limited efficacy when thrombosis is initiated by plaque hemorrhage.
  • Further research is needed to fully elucidate the mechanisms of plaque rupture and thrombosis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...